Photo of Ashim Malhotra

Ashim Malhotra, BPharm, PhD

Assistant Professor
503-352-7295
UC Box 
A192
Health Professions Building 2 375
Areas I Teach 

Teaching

Dr. Malhotra serves as assistant professor of pharmacology at the School of Pharmacy at Pacific University in Oregon. He is a combination pharmacist and molecular pharmacologist and has worked in academia for a decade. He has a strong record of research publications, book chapters, and research funding with an expertise in mitochondrial pharmacology. He has served as an invited grant reviewer for governmental programs conducted by the National Science Foundation (NSF) and other private foundations for funding biomedical research in the United States.  He has served as Chair of the national Sub-Committee on Strategic Planning for the Biological Sciences Section of the American Association of Colleges of Pharmacy (AACP). He is the School of Pharmacy’s Past Chair of Assessment, and the Chair Elect of Diversity of the College of Health Professions. He is the recipient of the 2016 Pacific University Junior Faculty Award, the 2016 AACP Teacher of the Year Award, and along with his colleagues, the 2014 AACP Innovations in Teaching Award. Before joining Pacific University, he worked at the NYU School of Medicine for five years and the New York Methodist Hospital for two years. He has trained Postdoctoral Fellows, graduate and undergraduate students at Pacific University, and at the NYU School of Medicine. He is invested in the provision of training opportunities to minorities underrepresented in the sciences to promote diversity and enjoys teaching pharmacology to prospective PharmD students. He has published papers and research posters with Pacific University student participation, and welcomes interest in his lab. For training opportunities with Dr. Malhotra, or Dr. Badejo who works in the Malhotra lab, please contact Dr. Malhotra directly.

School of Pharmacy

PHRM 561 | Biochemistry-II

PHRM 568 | Pulmonary, Cardiac and Renal Pathophysiology: Pharmaceutical and Medical Immunology, Inflammation, Cardiovascular and Renal Pathophysiology

PHRM 569 | Pulmonary, Cardiac and Renal Pharmacology

PHRM 581 | Pharmaceutical Sciences: Endocrine and Sex Hormones (Block Coordinator): Biochemistry of diabetes, Metabolic Syndrome

PHRM 583 | Pharmaceutical Sciences: Immunology and Toxicology: Basics of transplant rejection, immunosuppressive pharmacology and therapy

PHRM 766 | Clinical and Serological Immunology (Elective)

School of Audiology

AUD 513 | Pharmacology and Mechanisms of Ototoxicity

Education

2011 | Research Scientist, NYU School of Medicine in New York, New York

2006-2010 | Postdoctoral Fellowship, NYU School of Medicine in New York, New York

2008 | FPGEE Certification, National Association of the Boards of Pharmacy USA

2006 | Doctor of Philosophy, Life Sciences: Biochemistry and Molecular Pharmacology, Saint John’s University in Queens, New York

2003 | Master of Science, Saint John’s University in Queens, New York

2000 | Bachelor of Pharmacy, Hamdard University School of Pharmacy in New Delhi, India

Areas of Research & Specialization

I have two main areas of interest: (1) a pediatric cardiomyopathy called Barth Syndrome and (2) pancreatic cancer. In summary, I employ lipidomics and molecular pharmacology for an elucidation of disease mechanisms.

Barth Syndrome: In cardiomyopathy research, I investigate the molecular pathology of Barth Syndrome (BTHS). BTHS is a rare but fatal, X-linked dilated cardiomyopathy and skeletal myopathy arising due to mutations in the tafazzin gene, the protein product of which is a mitochondrial enzyme of the same name. My work has demonstrated that tafazzin is a transacylase responsible for remodeling the mitochondrial inner membrane phospholipid cardiolipin (CL). We also showed that mutated tafazzin caused myopathic mitochondrial aberrations. Specifically mutated tafazzin containing mitochondria had alterations in lipid profile and evinced cristae membrane collapse involving degenerate supramolecular protein assembly. There were also discrepancies in protein distribution of complex V (ATP synthase) and tafazzin in the mitochondrial supramolecular complexes and therefore perhaps delinquent cristae membrane packing. That this was relevant in the context of cardiocytes was demonstrated when we showed that tafazzin mutations affected mitochondrial development during cardiocyte differentiation. Further, in lymphoblasts obtained from BTHS patients, delinquent CL remodeling was accompanied with mitochondrial accrual of monolysocardiolpin (MLCL), the monodeacylated form of CL. Importantly, we provided evidence that MLCL accumulation could be reversed employing small molecule regulators of calcium independent phospholipase A2, suggesting that in addition to deficient membrane packaging, MLCL amassment was a crucial intracellular lesion in this syndrome. In my current work at the Pacific University School of Pharmacy, I am interested in the development and validation of putative translational therapeutics for Barth Syndrome (BTHS). I will explore the following two broad areas: (1) the role of acute and chronic inflammation in cardiomyopathy and (2) the regulation of mitochondrial calcium in BTHS. For these, I will employ molecular biology, lipidomics and proteomics tools.

Pancreatic Cancer: A recent area of research interest is investigation into the development and progression of pancreatic cancer. Although rarer than other forms of cancer, pancreatic carcinoma has a poor prognosis since it is usually discovered late. Of the many types of pancreatic neoplasia, I am interested in understanding the mechanistic development of pancreatic ductal dysplasia. In particular my emphasis is on the identification of natural compounds that cause apoptosis in pancreatic cancer cell lines. At the Pacific University School of Pharmacy, I aim to explore alterations in intracellular signal transduction pathways downstream of treating cells with natural compounds such as Diindolylmethane (DIM), Neem leaf extracts and other pharmacognostic agents. These exploratory studies will serve to provide preliminary data for translational therapeutic discovery.

Grants and Funding

2016 | Elsa U. Pardee Foundation Grant. Title: Identifying protein targets for overcoming chemoresistance in pancreatic cancer. Role: PI. Award: $107,755

2015 | Collins Medical Trust Oregon.  Role: Co-Investigator. Award: $30,000

2010 | National Pancreas Foundation Grant. Title: The role of dendritic cells in the immune progression of pancreatitis to pancreatic cancer. PI: Ashim Malhotra. Award: $50,000; completed 2011

2009 | Barth Syndrome Foundation Grant. Title: The distribution of tafazzin and cardiolpin in the mitochondrial supramolecular complexes – implications for Barth Syndrome. PI: Ashim Malhotra. Award: $24,000; completed 2010

2005 | Eli Lilly. Title: The effect of the anti-cancer drug mechlorethamine on mitochondrial membrane stability. PI:Dipak Haldar. Co-PI:Ashim Malhotra; completed 2006 

2004 | Eli Lilly. Title: Aging process in the mitochondria: effect on membrane structure. PI:Dipak Haldar. Co-PI: Ashim Malhotra; completed 2005

Professional Affiliations

American Association of the Colleges of Pharmacy (AACP )

American Heart Association (AHA)

New York Academy of Sciences (NYAS)

Publications

Book Chapters:

Doyle IC, Malhotra A. Chapter title: Polymers Used in Augmenting Immunosuppressive Therapy. Book Title: Handbook of Polymers for Pharmaceutical Technologies. Editors: V.K. Thakur and M.K. Thakur. Publisher: Wiley. July, 2015. 

Javan GT, Finley SJ, Can I, Salhotra A, Malhotra A, Soni S. Chapter title: Aberrant Signaling Pathways: Hallmark of Cancer Cells and Target for Nanotherapeutics. Publisher: Wiley. Published July 2015.

Malhotra A. Chapter title: Improving Matters of the Heart: Pharmaceutical Polymer Applications in Cardiology. Book Title: Handbook of Pharmaceutical Polymers. Editor: Vijay Kumar Thakur and Majula Kumari Thakur. Publishers: Wiley. Published July 2015.

Malhotra, A. "Nanotechnology Applications in Cardiology: Proof of Principle" in Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering, 2014. IGI Global Publishers.

Khan, F & Malhotra, A. "Introduction to Biochemistry" in Medicinal Chemistry for Pharmacy Students. Khan, F & Phillips, A (under contract, 2014 publication date). Jones and Bartlett Publishing: Boston, Mass.

Malhotra, A & Khan, F. "Pharmacology of Immunosuppressive Agents and Miscellaneous Drugs" in Medicinal Chemistry for Pharmacy Students. Khan, F & Phillips, A (under contract, 2014 publication date). Jones and Bartlett Publishing: Boston, Mass.

Malhotra, A. "Introduction to Pharmacogenomics" in Pharmacotherapeutics for Nurse Practitioner Prescribers, 4thed. Woo, TM & Robinson, ML (under contract, 2015 publication date). FA Davis: Philadelphia, Pa.

Peer Reviewed Journal Articles:

* Denotes Pacific University Student

2017: Amawi H, Karthikeyan C, Pathak R, Hussein N, Christman R, Robey R, Ashby CR Jr, Trivedi P, Malhotra A, Tiwari A. Thienopyrimidine derivatives exert their anticancer efficacy via apoptosis induction, oxidative stress and mitotic catastrophe. Eur J Med Chem. 138:1053-1065.

2017: Stamper BD, Buhler AV, Harrelson JP, Roberts SC, Malhotra A, Elbarbry FA, Rao D, Karimi R, Turner R, Marlow C, Devaud LL.Forecasting academic success through implementation of an online prerequisite review tutorials program for first year pharmacy studentsCurr Pharm Teach Learn. 9 (2), p 261–271.

2016: Bath S, Lines J, Loeffler AM, Malhotra A, Turner RB. Impact of standardization of antimicrobial prophylaxis duration in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2016: Accepted.

2015: Turner RB, Martello J, Malhotra A.  Worsening renal function in patients with baseline renal impairment treated with intravenous voriconazole: a systematic review. Int J Antimicrob Agents. 2015. pii: S0924-8579 (15) 00251-4. 

2015: Malhotra A, Bath SK, Elbarbry F. "An Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of Resveratrol" in Oxidative Medicine and Cellular Longevity. Article ID 803971.

2015: Xu Y, Malhotra A, Claypool SM, Ren M, Schlame M. "Tafazzins from Drosophila and mammalian cells assemble in large protein complexes with a short half-life" in Mitochondrion. pii: S1567-7249(15) 00003-3.

2014: Fulford MJ, Souza J, Alston GL, McLaughlin J, Garavalia L, Franson K, Fowles M, Malhotra A, et al. Are you CAPE-A.B.L.E.? Center for the Advancement of Pharmacy Education: An Assessment Blueprint for Learning Experiences. A white paper on CAPE assessment. American Association of the Colleges of Pharmacy.

2014: Malhotra A, Kahlon P*, Donhoe T, Doyle IC.  Pharmacogenomic considerations in the pediatric cardiomyoapthy called Barth Syndrome” in Recent Patents on Biotechnology. Special issue: Current Topics in Pharmacogenomics. In Press.

2014: Turner B, Grover  A, Malhotra A.  “The clinical management of pancreatic cancer” in US Pharmacist.

2011: Acehan D, Malhotra A, Xu Y, Ren M, Schlame M."Cardiolipin affects the supramolecular organization of ATP synthase in mitochondria" in Biophys J. 100 (9): 2184-92.

2011  Bedrosian AS, Nguyen AH, Hackman M, Connolly MK, Malhotra A, Ibrahim J, Cieza-Rubio NE, Henning JR, Barilla R, Rehman A, Pachter HL, Medina-Zea MV, Cohen SM, Frey AB, Acehan D, Miller G. "Dendritic cells promote pancreatic viability in mice with acute pancreatitis" in Gastroenterology. 141 (5): 1915-26

2011: Connolly M, Ayo D, Malhotra A, Hackman M, Ibrahim J, Bedrosian AS, Cieza-Rubio NE, Henning JR, Pachter HL, Frey AB, Miller G."Dendritic cell depletion exacerbates acetaminophen hepatotoxicity" in Hepatology.54 (3): 959-68

2010: Connolly MK, Bedrosian AS, Malhotra A, Henning JR, Ibrahim J, Vera V, Cieza-Rubio NE, Hassan BU, Pachter HL, Cohen S, Frey AB, Miller G. "In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity" in J Immunol. 185 (4): 2200-8.

2010: Malhotra A, Edelman-Novemsky I, Xu Y, Ma J, Schlame M, Ren M. "Genetic supressors of Barth Syndrome as potential targets for therapeutic intervention" in 2010. Mitochondrion. 10 (2): 207-208.

2009: Xu Y, Zhang S, Malhotra A, Edelman-Novemsky I, Ma J, Kruppa A, Cernicica C, Blais S, Neubert TA, Ren M, Schlame M."Characterization of tafazzin splice variants from humans and fruit flies" in J Biol Chem.284 (42): 29230-9.

2009: Malhotra A, Xu Y, Ren M, Schlame M."Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species" in Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 2009.1791 (4): 314-20.

2009: Malhotra A, Edelman-Novemsky I, Xu Y, Plesken H, Ma J, Schlame M, Ren M."Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome" in Proc Natl Acad Sci U S A. 106 (7): 2337-41

2009: Acehan D, Khuchua Z, Houtkooper RH, Malhotra A, Kaufman J, Vaz FM, Ren M, Rockman HA, Stokes DL, Schlame M."Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria" in Mitochondrion. 9 (2): 86-95

2009: Connolloy M, Mallen-St. Clair J, Bedrosian A, Malhotra A, Vera V, Ibrahim J, Pachter L, Bar-Sagi D, Frey A, Miller G. “Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor" in J Leuk Bio.87 (4): 713-25.

2006: Xu Y, Malhotra A, Ren M and Schlame M. "The enzymatic function of tafazzin" in J Biol Chem. 281 (51): 39217-24

Headlines

School of Pharmacy Assistant Professor Dr. Ashim Malhotra has edited and authored a book entitled, “Emerging Applications, Perspectives, and Discoveries in Cardiovascular Research”, published by IGI Global of Hershey, Pennsylvania. 

ASPET has bestowed this year's Pharmacology Educators award to Dr. Ashim Malhotra, Assistant Professor at the Pacific University School of Pharmacy.

The School of Pharmacy is excited to announce that Dr. Leslie Devaud has been awarded a $30,000 grant from the Collins Medical Trust to support her research on the establishment of a zebrafish colony at Pacific University.